Exercise Study in Subjects With NAFLD

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 19, 2019

Primary Completion Date

June 18, 2020

Study Completion Date

June 18, 2020

Conditions
Non-Alcoholic Fatty Liver DiseaseGastrointestinal MicrobiomeExercise
Interventions
BEHAVIORAL

high-intensity aerobic interval training

"The intervention group will follow a high-intensity interval training protocol on a cycle ergometer for 2 times per week and 1 time an individualised home workout program to have a total exercise amount of 3 hours.~Leisure time physical activity at baseline as well as during the intervention period will be assessed by Polar Active devices."

Trial Locations (1)

70200§§

University of Eastern Finland, Kuopio

Sponsors
All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute

OTHER

collaborator

Afekta

UNKNOWN

collaborator

Novogene

UNKNOWN

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Clinical Microbiomics

UNKNOWN

collaborator

Kuopio Research Institute of Exercise Medicine

OTHER

collaborator

Kuopio University Hospital

OTHER

lead

University of Eastern Finland

OTHER

NCT03995056 - Exercise Study in Subjects With NAFLD | Biotech Hunter | Biotech Hunter